InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
7
T+90 hit rate
100%
T+90 mean return
+23.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Gorevic Jason N, Chief Executive Officer. Insider active across 2 companies, notably Teladoc Health, Inc.. Aggregated, 23 disclosures have been logged. Split: 3 buys · 7 sells. Total volume traded: €4.6m. History available since 4 May 2021. The latest transaction was disclosed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gorevic Jason N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
5,000 shares@ US$25.91Common StockSEC:0001208500-26-000004:0
Canonical exit: 8 Nov 2026 (T+90)
2,000 shares@ US$49.1438.8% of flowCommon StockSEC:0001208500-25-000003:0
Canonical exit: 5 Nov 2025 (T+90)
2,435 shares@ US$61.61100.0% of flowCommon StockSEC:0000860748-25-000144:0
2,565 shares0Common StockSEC:0000860748-24-000153:0
21,130 sharesCommon StockSEC:0001477449-24-000044:0
5,615 sharesCommon StockSEC:0001477449-23-000101:0
5,614 sharesCommon StockSEC:0001477449-23-000037:0
10,000 shares@ US$30.03033.5% of flowCommon StockSEC:0001477449-23-000016:0
5,614 sharesCommon StockSEC:0001415889-23-009195:0
2,933 shares0Common StockSEC:0000860748-23-000101:0
22,040 shares@ US$25.9117.0% of flowCommon StockSEC:0001415889-23-004415:0
22,458 sharesCommon StockSEC:0001415889-23-004099:0
3,000 shares@ US$43.00100.0% of flowCommon StockSEC:0000860748-22-000140:0
Canonical exit: 1 Nov 2022 (T+90)
2,525 shares0Common StockSEC:0000860748-22-000090:0
16,778 sharesCommon StockSEC:0001179110-22-002053:0
9,103 sharesCommon StockSEC:0001415889-22-002568:0
614 shares0Common StockSEC:0000860748-22-000021:0
5,237 shares@ US$150.325915.6% of flowCommon StockSEC:0001179110-21-009877:0
10,000 shares@ US$150.116929.1% of flowCommon StockSEC:0001179110-21-007943:0
1,000 shares@ US$161.27213.1% of flowCommon StockSEC:0001179110-21-007427:0
10,000 shares@ US$153.3428.9% of flowCommon StockSEC:0001179110-21-006211:0
23,067 shares@ US$1.670.8% of flowCommon StockSEC:0001179110-21-005054:0
1,300 shares@ US$154.11853.8% of flowCommon StockSEC:0001179110-21-004948:0
23 of 23 declarations
About Gorevic Jason N
As Directeur Général, GOREVIC JASON N has filed 22 disclosures. Across the 22 sampled filings, the recent transactions run from 2021-05-06 to 2025-08-07, with EUR 211166 of purchases and EUR 4313924 of sales, and the most common transaction type is Levée d'options. He is also linked to Teladoc Health, Inc., where the listed role is CHIEF EXECUTIVE OFFICER, and to KEMPER Corp, where the listed role is Director.
